Elanco Animal Health Incorporated
US ˙ NYSE ˙ US28414H1032

SecurityELAN / Elanco Animal Health Incorporated
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership145,018 shares
Latest Disclosed Value $ 3,470,281
D. E. Shaw & Co., Inc. reports 23.98% increase in ownership of ELAN / Elanco Animal Health Incorporated

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 145,018 shares of Elanco Animal Health Incorporated (US:ELAN) valued at $3,470,281 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 116,968 shares of Elanco Animal Health Incorporated. This represents a change in shares of 23.98% during the quarter. The current value of the position is $3,563,092 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 145,018 28,050 23.98 3,470 31.14 0.0021
2026-02-17 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 116,968 -72,436 -38.24 2,647 -30.62 0.0015
2025-11-14 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 189,404 -25,684 -11.94 3,815 24.19 0.0022
2025-08-14 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 215,088 -168,463 -43.92 3,071 -23.74 0.0022
2025-05-15 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 383,551 -277,088 -41.94 4,027 -49.66 0.0036
2025-02-14 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 660,639 -367,985 -35.77 8,000 -47.05 0.0059
2024-11-14 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,028,624 -1,502,831 -59.37 15,110 -58.63 0.0130
2024-08-14 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 2,531,455 -1,756,934 -40.97 36,529 -47.68 0.0342
2024-05-15 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 4,288,389 -166,587 -3.74 69,815 5.17 0.0597
2024-02-14 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 4,454,976 -635,685 -12.49 66,379 16.01 0.0580
2023-11-14 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 5,090,661 -4,423,987 -46.50 57,219 -40.22 0.0597
2023-08-14 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 9,514,648 1,680,380 21.45 95,717 29.98 0.0978
2023-05-15 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 7,834,268 -577,953 -6.87 73,642 -28.36 0.0788
2023-02-14 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 8,412,221 2,790,134 49.63 102,797 47.34 0.1136
2022-11-14 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 5,622,087 3,152,960 127.70 69,770 43.95 0.0833
2022-08-15 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 2,469,127 -472,315 -16.06 48,469 -36.84 0.0568
2022-05-16 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 2,941,442 -967,969 -24.76 76,742 -30.83 0.0718
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 3,909,411 2,287,366 141.02 110,949 114.49 0.0920
2021-11-15 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,622,045 -943,974 -36.79 51,727 -41.89 0.0467
2021-08-16 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 2,566,019 1,908,455 290.23 89,015 359.67 0.0768
2021-05-17 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 657,564 285,551 76.76 19,365 69.72 0.0187
2021-02-16 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 372,013 -284,487 -43.33 11,410 -37.77 0.0102
2020-11-16 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 656,500 -1,116,007 -62.96 18,336 -51.77 0.0188
2020-08-14 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,772,507 -1,406,462 -44.24 38,021 -46.58 0.0453
2020-05-15 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 3,178,969 18,627 0.59 71,177 -23.52 0.1110
2020-02-14 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 3,160,342 1,674,553 112.70 93,072 135.58 0.1064
2019-11-14 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,485,789 543,418 57.66 39,507 24.03 0.0486
2019-08-14 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 942,371 -169,907 -15.28 31,852 -10.71 0.0397
2019-05-15 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,112,278 -369,971 -24.96 35,671 -23.67 0.0461
2019-02-14 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,482,249 475,755 47.27 46,735 33.08 0.0644
2018-11-14 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,006,494 1,006,494 35,117 0.0422
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.